Expected earnings - Innate Pharma S.A.
Source: US Earnings Reports
Innate Pharma S.A. (IPHA) is expected to report for Q2 2025
Innate Pharma S.A.
NASDAQ: IPHA
IPHA Trading
-7.74% G/L:
$1.43 Last:
16,665 Volume:
$1.50 Open:
IPHA Latest News
February 19, 2026 01:00:00 am
Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
February 18, 2026 01:00:00 am
Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
December 22, 2025 01:00:00 am
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
IPHA Stock Data
$162,196,580
59,035,869
N/A
7
N/A
Biotechnology & Life Sciences
Healthcare
FR
Marseille
